Helen Davies
- Documentation & accuracy of smoking status – An educational need?By James Redfern, Saagar Patel, Jemma Plant, Gilly Ennals, Helen Gittins, Marianne Schrober, Andrea Collins, Dilip Nazareth and Lisa DaviesJames RedfernAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomSaagar PatelAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomJemma PlantAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomGilly EnnalsAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomHelen GittinsAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomMarianne SchroberAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomAndrea CollinsAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomDilip NazarethAintree Chest Centre, University Hospital Aintree, Liverpool, United KingdomLisa DaviesAintree Chest Centre, University Hospital Aintree, Liverpool, United Kingdom
- Smoking cessation advice (SCA) and referral: Do we need to further educate healthcare professionals?By Helen Gittins, Saagar Patel, Gilly Ennals, Jemma Plant, James Redfern, Marianne Shober, Andrea Collins, Dilip Nazareth and Lisa DaviesHelen GittinsRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomSaagar PatelRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomGilly EnnalsRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomJemma PlantRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomJames RedfernRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomMarianne ShoberRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomAndrea CollinsRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomDilip NazarethRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United KingdomLisa DaviesRespiratory Medicine, University Hospital Aintree, Liverpool, Merseyside, United Kingdom
- The second therapeutic intervention in malignant effusion trial (TIME2): A randomised controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion drainage by indwelling pleural catheter compared to chest drain and talc slurry pleurodesisBy Eleanor Mishra, Helen Davies, John Wrightson, Andrew Stanton, Anur Guhan, Christopher Davies, Jamal Grayez, Richard Harrison, Anjani Prasad, Nicky Crosthwaite, Y.C. Gary Lee, Robert Miller, Brennan Kahan and Najib RahmanEleanor Mishra1Oxford Respiratory Trials Unit, University of Oxford, Oxfordshire, United KingdomHelen Davies2Department of Respiratory Medicine, University Hospital of Wales, Cardiff, United KingdomJohn Wrightson1Oxford Respiratory Trials Unit, University of Oxford, Oxfordshire, United KingdomAndrew Stanton3Department of Respiratory Medicine, Great Western Hospital, Swindon, United KingdomAnur Guhan4Department of Respiratory Medicine, James Cook University Hospital, South Tees, United KingdomChristopher Davies5Department of Respiratory Medicine, Royal Berkshire Hospital, Reading, United KingdomJamal Grayez6Department of Respiratory Medicine, Horton Hospital, Banbury, United KingdomRichard Harrison7Department of Respiratory Medicine, University Hospital, North Tees, United KingdomAnjani Prasad8Department of Respiratory Medicine, Buckinghamshire Hospitals NHS Trust, High Wycombe, United KingdomNicky Crosthwaite1Oxford Respiratory Trials Unit, University of Oxford, Oxfordshire, United KingdomY.C. Gary Lee9Department of Respiratory Medicine, University of Western Australia, Perth, AustraliaRobert Miller10Department of Genitourinary Medicine, University College London, United KingdomBrennan Kahan11Department of Statistics, Medical Research Council, London, United KingdomNajib Rahman1Oxford Respiratory Trials Unit, University of Oxford, Oxfordshire, United Kingdom
- Effect of ivacaftor on lung clearance index and FEV1 in subjects with CF who have the G551D-CFTR mutation and mild lung diseaseBy Felix Ratjen, Helen Sheridan, Po-Shun Lee, Tao Song, Anne Stone and Jane DaviesFelix Ratjen1Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, CanadaHelen Sheridan2Department of Child Life and Health, University of Edinburgh, United KingdomPo-Shun Lee3Clinical Research and Biostatistics, Vertex Pharmaceuticals Incorporated, Cambridge, United StatesTao Song3Clinical Research and Biostatistics, Vertex Pharmaceuticals Incorporated, Cambridge, United StatesAnne Stone3Clinical Research and Biostatistics, Vertex Pharmaceuticals Incorporated, Cambridge, United StatesJane Davies4Paediatric Respiratory Medicine & Gene Therapy, Royal Brompton Hospital and Imperial College, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.